Senior Research Associate based at the University of Bristol with 12 years of research experience in a dynamic research group. My work primarily focuses on developing biomarker assays and utilizing islet autoantibodies and other biomarkers to predict, classify, and understand autoimmunity in type 1 diabetes and related autoimmunity. I am enthusiastic and passionate about translational bench-to-bedside research with verifiable impact to health outcomes. To date, this is evidenced through my publications of my clinical collaborations to investigate insulin autoimmine syndrome and my ongoing research collaboration in developing diagnostic assays.

My research interests and current projects and collaborations include:

• Characterising type 1 diabetes in under-represented populations such as Sub-Saharan Africa.
• Characterising type 1 diabetes across the age spectrum - clear differences are increasingly described in childhood-onset and adulthood-onset type 1 diabetes.
• The natural history of type 1 diabetes in individuals with familal history of type 1 diabetes (~15% of cases) and in individuals without familal history of type 1 diabetes (85%) through family cohorts and general population screening studies.
• Identifying and characterising novel biomarkers (e.g., exocrine and immune cell) to inform the variable progression rate from identification of autoimmune biomarkers to the development of clinical type 1 diabetes.
• Develop new biomarker assays that can inform/refine risk prediction modelling of clinical onset and response to therapy (e.g., immunotherapies).